Perritt Capital Management Inc Harrow Health, Inc. Transaction History

Perritt Capital Management Inc

  • $185 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$10.28 - $14.78 $225,738 - $324,554
-21,959 Reduced 73.2%
8,041 $118,000
Q3 2022

Nov 14, 2022
BUY
$6.57 - $24.88 $128,509 - $486,652
19,560 Added 187.36%
30,000 $362,000
Q2 2022

Aug 15, 2022
BUY
$5.75 - $7.74 $60,030 - $80,805
10,440 New
10,440 $76,000

Others Institutions Holding HROW

# of Institutions
174
Shares Held
21.2M
Call Options Held
844K
Put Options Held
698K
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $854M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Perritt Capital Management Inc Portfolio

Follow Perritt Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email